MedPath

Analysis of the effect and side effects of desmopressin melt in patients with nocturnal polyuria.

Phase 1
Conditions
octuria and noctural polyuria
Registration Number
EUCTR2011-000666-35-BE
Lead Sponsor
Ghent University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

- Written informed consent prior to the performance of any study-related activity
- Patients 18 years and older with an average of = 2 nocturnal voids per night

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

- hypersensitivity/anaphylactic reaction on desmopressin or one of the other substances
- pregnancy
- genito-urinary tract pathology (infection, tumor,...)
- urolithiasis
- suspicion or evidence of cardiac failure
- moderate to severe renal insufficiency (creatinin clearance < 50 ml/min)
- psychogenic or habitual polydipsia
- hyponatriemia or predisposition for hyponatriemia
- diabetes insipidus
- syndrome of inadequate ADH production

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath